[NBY] QoQ Quarter Result on 30-Sep-2022 [#Q3]

Stock
[NBY] NovaBay Pharmaceuticals, Inc.
Announcement Date
14-Nov-2022
Financial Year
2022
Quarter
30-Sep-2022 [#Q3]
Profit Trend
QoQ- -168.82%
YoY- -153.08%
Quarter Report
NBY's Result
NBY's Financial Summary
View:
Show?
Quarter Result
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
Revenue 4,610 3,124 3,643 3,826 3,045 2,629 2,641 45.12%
PBT -2,036 -1,739 -8,206 -136 -2,155 -111 -158 452.22%
Tax -256 5 -3,488 -321 3 -2,271 735 -
NP -4,032 -1,739 -8,206 -5,793 -2,155 -111 -893 173.93%
Tax Rate - - - - - - - -
Total Cost 8,642 4,863 11,849 9,619 5,200 2,740 3,534 81.80%
Ratio Analysis
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
NP Margin -87.46 -55.67 -225.25 -151.41 -70.77 -4.22 -33.81 88.76%
Per Share
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
EPS -1.27 -0.85 -4.33 -3.61 -1.43 -0.08 -0.69 50.35%
EPS Diluted -1.27 -0.85 -4.33 -3.61 -1.43 -0.08 -0.69 50.35%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.